The difference lies in the dosage and approval: Wegovy uses a higher dose (up to 2.4 mg per week) and has been approved for people with: A BMI of 30 or higher, or A BMI of 27+ with a related health condition (such as high blood pressure or type 2 diabetes) Because of its targeted purpose, Wegovy is often the better option for patients focused solely on weight loss in Ontario especially when paired with nutritional and behavioural support
If someone is diabetic or maybe pre-diabetic, then you may have a situation where your blood glucose goes high, and it's difficult to control." Symptoms of high blood glucose levels can include excessive thirst, frequent urination, headache and fatigue, and they can lead to dehydration, dizziness and nausea or vomiting
65 Because of concerns about unexpected death on account of respiratory obstruction early in growth hormone treatment, sleep polysomnography and assessment for enlarged tonsils and adenoids are recommended before initiating growth hormone treatment and 68 weeks after starting
De Lonlay P, Benelli C, Fouque F, et al
& Sampalis, J
